MXCT News and Press, MaxCyte Inc.

ROCKVILLE, Md., May 29, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bio...

2024-05-24 05:05:00 ET Summary RGA Investment Advisors are an independent, fee-only investment management firm providing wealth management and financial planning for individuals, families, non-profit firms, and corporations of all sizes. In the first quarter, the macroeconomic env...

ROCKVILLE, Md., May 22, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc . , (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics and inn...

2024-05-11 08:35:22 ET MaxCyte, Inc. (MXCT) Q1 2024 Earnings Call Transcript May 7, 2024 04:30 PM ET Company Participants Erik Abdow - Investor Relations Maher Masoud - President & Chief Executive Officer Douglas Swirsky - Chief Financial Officer Confer...

2024-05-08 12:52:00 ET More on mid-day movers & stocks. MaxCyte, Inc. (MXCT) Q4 2023 Earnings Call Transcript iSun to effect 1-for-20 reverse stock split to regain Nasdaq compliance Financial information for Davis Commodities Limited Seeking Alpha’...

2024-05-08 10:00:08 ET More on Health Care Select Sector SPDR XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance 16 out...

2024-05-07 16:28:16 ET More on MaxCyte MaxCyte, Inc. (MXCT) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on MaxCyte Historical earnings data for MaxCyte Financial information for MaxCyte Read the full article on Seeking Alpha...

ROCKVILLE, Md., May 07, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell therapeutics and innovative bioproce...

Aterian Inc. (ATER) is expected to report for Q1 2024 Dorman Products Inc. (DORM) is expected to report $0.82 for Q1 2024 Hillman Solutions Corp. (HLMN) is expected to report $0.08 for Q1 2024 Wake Forest Bancshares, Inc. (WAKE) is expected to report for quarter end 2024-03-31 Inn...

ROCKVILLE, Md., April 10, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and innovative bioproc...